🏥 I am a board-certified Attending Surgical Oncologist with a PhD in Oncology, currently serving as Director of Drug Discovery and Full Project Scientist at the Sanford Stem Cell Institute, University of California, San Diego. 🔬 My research focuses on cancer immunotherapy, cancer stem cells (CSCs), and nanomedicine. I develop therapies enhancing immune responses against tumors, target CSCs through Notch1 and ADAR1 pathways, and lead the preclinical development of Rebecsinib, a selective small-molecule inhibitor that suppresses leukemia stem cell (LSC) self-renewal. In nanomedicine, I advance peptide-based drug delivery platforms for targeted therapeutics. 🎓 Previously, I served as Dean and Distinguished Professor at the School of Medicine, Huzhou University, leading initiatives that elevated the Clinical Medicine Program to first-tier status. 📝 I serve as Associate Editor for Frontiers in Immunology and Frontiers in Oncology, Guest Editor for Frontiers in Immunology, Cancers, and Oncology Research, and Editorial Board Member for Oncology Research, Discover Oncology, Oncology Advances, and the World Journal of Clinical Oncology. 🧪 I have reviewed for 82 scientific journals since 2006 and serve as a grant reviewer for the European Science Foundation (ESF), Research Foundation Flanders (FWO), and the French National Institute of Health and Medical Research (INSERM).